Washington Trust’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q1
Sell
-100,153
Closed -$6.42M 229
2018
Q4
$6.42M Sell
100,153
-20,045
-17% -$1.48M 0.41% 77
2018
Q3
$10.8M Sell
120,198
-4,364
-4% -$386K 0.58% 60
2018
Q2
$9.89M Sell
124,562
-3,272
-3% -$272K 0.53% 63
2018
Q1
$11.4M Sell
127,834
-7,251
-5% -$696K 0.67% 53
2017
Q4
$14.1M Buy
135,085
+361
+0.3% +$40.7K 0.79% 46
2017
Q3
$19.6M Sell
134,724
-1,015
-0.7% -$138K 1.17% 32
2017
Q2
$17.6M Sell
135,739
-343
-0.3% -$42K 1.07% 35
2017
Q1
$16.9M Sell
136,082
-4,662
-3% -$558K 1.07% 36
2016
Q4
$16.3M Sell
140,744
-4,933
-3% -$549K 1.05% 37
2016
Q3
$15.2M Sell
145,677
-4,749
-3% -$514K 1% 40
2016
Q2
$14.8M Sell
150,426
-5,683
-4% -$588K 1% 39
2016
Q1
$15.6M Buy
156,109
+9,296
+6% +$957K 1.04% 38
2015
Q4
$17.6M Sell
146,813
-5,640
-4% -$653K 1.2% 33
2015
Q3
$16.5M Sell
152,453
-6,476
-4% -$804K 1.19% 32
2015
Q2
$18.4M Buy
158,929
+3,962
+3% +$453K 1.21% 32
2015
Q1
$17.9M Buy
154,967
+3,507
+2% +$419K 1.19% 33
2014
Q4
$16.9M Buy
151,460
+1,739
+1% +$183K 1.16% 30
2014
Q3
$14.2M Buy
149,721
+5,924
+4% +$535K 1.04% 37
2014
Q2
$12.3M Buy
143,797
+22,909
+19% +$1.74M 0.91% 42
2014
Q1
$8.44M Buy
+120,888
New +$9.57M 0.63% 59

Other funds holding CELG

Washington Trust's CELG Position: Q1 2019 in Review

Washington Trust sold out of Celgene Corp (CELG) in Q1 2019, closing a stake of 100,153 shares — an estimated $6.42M sold.

Washington Trust first reported a position in CELG in Q1 2014 and held it in 20 quarters. The position peaked at $19.6M in Q3 2017. 1,389 funds tracked by Wall St. Rank hold CELG as of Q1 2019.

  • Washington Trust reported no remaining Celgene Corp position as of Q1 2019 after selling out during the quarter.
  • Washington Trust sold 100,153 Celgene Corp shares in Q1 2019, an estimated $6.42M.
  • Washington Trust first reported a position in Celgene Corp in Q1 2014 and held it in 20 quarters.
  • Washington Trust's Celgene Corp position peaked at $19.6M in Q3 2017.
  • 1,389 funds tracked by Wall St. Rank held Celgene Corp as of Q1 2019.

Based on Washington Trust's 13F filing for Q1 2019, filed 13 May 2019.